Companies have realized the era of innovation and advance drug developments is around the corner. One of the key areas that is witnessing a surge is monoclonal antibodies.
Global biologics sales crossed $411 billion in 2024, with top-performing therapies treating cancer, autoimmune disorders, and rare diseases.
The design and development of orphan drugs, designed for rare diseases, are uniquely challenged as limited patient populations available for clinical trials.
Harnessing continuous data to accelerate clinical discovery, driving innovation with real-time insights and transformative solutions for healthcare breakthroughs.
Explore how digital tools are transforming patient engagement in cardiometabolic trials, enhancing recruitment, retention, and real-world data collection.
1 September 2025
23 August 2025
18 August 2025
4 August 2025
26 June 2025
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com